诱惑受体作为用于探索病因和设计新疗法的生物标志物
Carmine Zoccali1,2,3, Giovanni Tripepi4, Vianda Stel5,6
1Renal Research Institute, NY, USA.
Clinical kidney journal
|August 26, 2024
概括
溶性诱受体 (DR) 作为分子陷,提供生物标志物和治疗药物的潜力. 这些受体调节炎症和信号通路,显示出治疗心血管和脏疾病的前景.
科学领域:
- 生物化学 生物化学
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
背景情况:
- 溶性诱受体 (DR) 是循环的蛋白质,可以中和连接体,影响细胞信号通路.
- 在各种疾病状态中,DR已经证明了其作为生物标志物和治疗剂的潜力.
- 炎症是一个关键的领域,DRs,像可溶性瘤亡因子受体 (sTNFRs),可以抑制促炎性细胞因子信号传递.
研究的目的:
- 探索可溶性诱受体 (DR) 作为生物标志物和治疗剂的作用.
- 研究DRs在调节疾病干预的炎症和信号通路方面的潜力.
- 突出DRs在诸如心血管疾病 (CVD) 和慢性病 (CKD) 等疾病中的重要性.
主要方法:
- 关于可溶性诱受体及其功能的现有文献的审查.
- 分析DRs与亲炎性细胞因子和高级糖化终产物 (AGEs) 等连接体相互作用的机制.
- 检查DRs的临床相关性,包括它们与疾病风险和进展的关联.
主要成果:
- 可溶性诱受体 (DRs) 有效地捕获连接体,调节关键信号通路.
- 炎症性DRs,如可溶性瘤亡因子受体 (sTNFRs),抑制炎症信号,为炎症条件提供治疗潜力.
- 高级糖化终产品 (sRAGE) 的可溶性受体与AGE结合,减轻血管功能障碍和动脉样硬化;较高的sRAGE水平与心血管事件风险降低相关.
结论:
- 溶性诱受体 (DRs) 作为生物标志物和治疗剂都具有显著的前景.
- 抗抑郁药物调节信号通路的能力为治疗炎症,心血管和脏疾病提供了新的机会.
- 对DR的进一步研究可以促进疾病机制的理解,并改善患者的治疗结果.
更多相关视频
06:01Extracellular Protein Microarray Technology for High Throughput Detection of Low Affinity Receptor-Ligand Interactions
Published on: January 7, 2019
7.2K
10:19High-throughput Flow Cytometry Cell-based Assay to Detect Antibodies to N-Methyl-D-aspartate Receptor or Dopamine-2 Receptor in Human Serum
Published on: November 23, 2013
16.3K
相关概念视频
Transducer Mechanism: Enzyme-Linked Receptors
2.4K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.4K
G Protein-coupled Receptors
11.6K
G Protein-Coupled Receptors or GPCRs are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to sensory stimuli such as light, odors, hormones, cytokines, or neurotransmitters.
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
11.6K
Transducer Mechanism: G Protein–Coupled Receptors
1.9K
G Protein–Coupled Receptors (GPCRs) are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to various stimuli. GPCRs regulate critical physiological pathways and are excellent drug targets for treating diseases such as diabetes, cancer, obesity, depression, or Alzheimer's. Nearly 35% of approved drugs implement their therapeutic effects by selectively interacting with specific GPCRs.
GPCRs are also called heptahelical,...
GPCRs are also called heptahelical,...
1.9K
